IDO1 and Hepatic fibrosis: Coa and coworkers reported that IDO inhibition via Danshensu—a bioactive component isolated from Danshen—reduced liver fibrosis in CCl4-treated rats and hepatic stellate cells exposed to TGF-β [27].